domingo, 28 de julio de 2013

PHGR: The Future of Cancer Screening: Public Health Approaches

PHGR: The Future of Cancer Screening: Public Health Approaches

The Future of Cancer Screening: Implications of New Genomic Knowledge

silver balls and one red ball
CDC Public Health Grand Rounds: Future of cancer screening: Public health approaches
CDC blog post: How can we use genetic testing in population screening for common diseases? Scientific and implementation challenges
CDC paper: How can polygenic inheritance be used in population screening for common diseases?External Web Site Icon
Khoury MJ et al. Genetics in Medicine Feb 14, 2013
Public health implications of genomics  and potential for risk stratification and screeningExternal Web Site Icon
Hilary Burton et al. Nature Genetics 2013;45:349-351
Future cancer screening may be improved by the use of genetic information,External Web Site Icon PHG Foundation, March 27
CDC information: Breast and ovarian cancer and family health history
CDC information: Genetic testing for breast and ovarian cancer

The Future of Cancer Screening: Public Health Approaches

Tuesday, July 16, at 1 p.m. - 2 p.m., EDT
Group of people Cancer is the second-leading cause of death among Americans and takes a toll on communities across the United States. One of the effective ways to reduce our nation’s burden from cancer is to ensure that high quality screening services are available and accessible to all Americans.  Screening for cervical, colorectal, and breast cancers is supported by sound scientific evidence, and helps find these diseases early when they are easiest to treat.
This session of Grand Rounds explored new ways that public health can increase the rate of evidence-based cancer screening, and decrease disparities in screening rates. Viewers learned about the effectiveness of screening, successful organized cancer screening programs in the United States and abroad, and opportunities with the Affordable Care Act. The session concluded with future directions for CDC and the nation’s public health system to improve cancer screening.
Future Grand Rounds topics include advanced molecular detection and antibiotic use.


Beyond the Data Beyond brings you “take home” messages for you to use in your practice, in your classroom and in your home.
Dr. John Iskander and Dr. Marcus Plescia discuss the approaches necessary to improve cancer prevention screening rates

Presented By

Otis W. Brawley, MD
Chief Medical Officer
American Cancer Society
“Public Health Impact of Cancer Screening”                                                       
Rachel Ballard-Barbash, MD, MPH
Associate Director, Applied Research Program
Division of Cancer Prevention and Control and Population Services
National Cancer Institute
“Cancer Screening in International Settings: What We Can Learn?”
Ned Calonge, MD
President and CEO, The Colorado Trust
Associate Professor, Family Medicine, University of Colorado
Associate Professor, Epidemiology, Colorado School of Public
“The Affordable Care Act: Opportunities to Improve Population Based Cancer Screening”
Theodore R. Levin, MD
Clinical Lead for Colorectal Cancer Screening, The Permanente Medical Group, Inc
Chief of Gastroenterology, Kaiser Permanente Medical
“Organized Cancer Screening in a U.S. Healthcare Setting: What Works”
Marcus Plescia, MD, MPH
Director, Division of Cancer Prevention and Control
National Center for Chronic Disease Prevention and Health Promotion, CDC
“The Role of Public Health in Organized Cancer Screening”
E-mail your questions about this topic before or during the session.
Watch the live broadcast at either of the following links:

Facilitated By

Tanja Popovic, MD, PhD, Scientific Director, Public Health Grand Rounds
John Iskander, MD, MPH, Deputy Scientific Director, Public Health Grand Rounds
Susan Laird, MSN, RN, Communications Manager, Public Health Grand Rounds

Additional Resources

Grand Rounds is available for Continuing Education. Learn more about continuing education on the Grand Rounds website.

No hay comentarios:

Publicar un comentario